이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

CIRCA-MED WP1 & WP3 - Circadian Rhythms in ICU Patients

2026년 9월 3일 업데이트: Felix Balzer, Charite University, Berlin, Germany

Retrospective Characterization of Circadian Rhythms Using Vital Signs and Other Routine Data From Patients in the Intensive Care Unit

The goal of this retrospective exploratory study is to examine how the body's natural day-and-night rhythms and oscillatory patterns behave in people who were treated in the Intensive Care Unit (ICU). The study uses routine clinical data that were already collected during and after the ICU stay, including post-discharge follow-up measurements (where available), such as heart rate, temperature, blood pressure, blood sugar, and insulin. The researchers want to learn whether these measurements show daily patterns and whether patients can be grouped based on their oscillatory profiles. The study also examines whether certain clinical factors such as illness severity scores, sedation levels, organ support treatments, or medications are associated with changes in these oscillatory rhythms. The team will explore whether conditions that can develop during or after critical illness, such as delirium, muscle weakness, or Post-Intensive Care Syndrome (PICS), are linked to disturbed physiological rhythms. Another goal is to test whether it is technically possible to show a patient's rhythm profile in real time using routine data from the ICU information system, evaluated retrospectively. Digital tools called "Chrono-Apps" will be developed to display rhythmic information and may help clinicians adjust lighting to patient needs.

연구 개요

상세 설명

The investigators will retrospectively analyze periodic oscillations in clinical data, such as heart rate, temperature, blood glucose, insulin, or blood pressure, to identify parameters suitable for characterizing the physiological rhythms in hospitalized Intensive Care Unit (ICU) patients. While these measurements typically show regular daily changes, also called oscillatory patterns, critical illness, continuous monitoring, and frequent medical interventions can disrupt them. The study will investigate whether these patterns can be used to group patients into distinct temporal or rhythmic profiles. The study will also examine whether certain clinical factors are linked to functioning or disrupted oscillatory patterns. These factors include illness severity scores, sedation levels, organ support treatments, and medications. Additionally, the researchers will explore whether temporal disruption is associated with key ICU complications, including delirium, ICU-acquired muscle weakness, and Post-Intensive Care Syndrome (PICS). Finally, in a small cohort of ICU patients, the investigators will test personalized lighting regimens adapted to individual chronotypes. This phase of the study aims to assess the robustness of routine clinical data for tailoring light exposure, validate a circadian entrainment algorithm, and evaluate potential sources of bias. Real-time analyses of clinical data will be visualized as rhythm profiles via digital "Chrono-Apps" integrated into the electronic patient record. These visualizations will support the day-to-day implementation of personalized lighting regimens that adapt dynamically to each patient's current rhythm status and clinical condition.

연구 유형

관찰

등록 (추정된)

25000

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Berlin, 독일, 10117
        • Institute of Medical Informatics, Charite University, Berlin

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

샘플링 방법

비확률 샘플

연구 인구

Charite University, Berlin, Germany

설명

Inclusion Criteria:

Primary Retrospective Cohort:

  • Admitted to and treated in a participating Intensive Care Unit (ICU) between 2017 and 2024
  • Minimum ICU length of stay of 3 days (≥ 72 hours)
  • Age ≥ 18 years at the time of ICU admission
  • All genders (male, female, diverse)

Cohorts from previous studies:

  • Prior enrollment in one of the designated parent study protocols
  • Availability of supplementary biological or metabolic data (e.g., clock gene expression, melatonin levels) suitable for exploratory association analyses

Exclusion Criteria:

  • None

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

코호트 및 개입

그룹/코호트
개입 / 치료
All retrospective patients between 2017 and 2024
Relates to retrospective data from all patients who spent at least three days in participating intensive care units at Charite University, Berlin, Germany between 2017 and 2024
These are the primary exposures and are used to detect oscillatory patterns and characterize circadian rhythms. They include heart rate, body temperature, blood pressure, blood glucose, and insulin.
These are secondary exposures that may influence circadian rhythms: illness severity (e.g., Sequential Organ Failure Assessment (SOFA) score), sedation levels, organ support therapies (e.g., ventilation, dialysis, Extracorporeal Membrane Oxygenation (ECMO)), and medications administered during ICU stay (e.g., sedatives, vasopressors, corticosteroids).
These exposures represent complications that may be associated with circadian disruption: delirium, deep sedation, ICU-acquired muscle weakness, and post-intensive care syndrome.
Pa-COVID (DRKS00021688)
These are the primary exposures and are used to detect oscillatory patterns and characterize circadian rhythms. They include heart rate, body temperature, blood pressure, blood glucose, and insulin.
These are secondary exposures that may influence circadian rhythms: illness severity (e.g., Sequential Organ Failure Assessment (SOFA) score), sedation levels, organ support therapies (e.g., ventilation, dialysis, Extracorporeal Membrane Oxygenation (ECMO)), and medications administered during ICU stay (e.g., sedatives, vasopressors, corticosteroids).
These exposures represent complications that may be associated with circadian disruption: delirium, deep sedation, ICU-acquired muscle weakness, and post-intensive care syndrome.
These exposures reflect biological clock function: clock gene expression (if available in some cases), and melatonin levels.
SeptiCLOCK (NCT02044575)
These are the primary exposures and are used to detect oscillatory patterns and characterize circadian rhythms. They include heart rate, body temperature, blood pressure, blood glucose, and insulin.
These are secondary exposures that may influence circadian rhythms: illness severity (e.g., Sequential Organ Failure Assessment (SOFA) score), sedation levels, organ support therapies (e.g., ventilation, dialysis, Extracorporeal Membrane Oxygenation (ECMO)), and medications administered during ICU stay (e.g., sedatives, vasopressors, corticosteroids).
These exposures represent complications that may be associated with circadian disruption: delirium, deep sedation, ICU-acquired muscle weakness, and post-intensive care syndrome.
These exposures reflect biological clock function: clock gene expression (if available in some cases), and melatonin levels.
VITALITY (NCT02143661)
These are the primary exposures and are used to detect oscillatory patterns and characterize circadian rhythms. They include heart rate, body temperature, blood pressure, blood glucose, and insulin.
These are secondary exposures that may influence circadian rhythms: illness severity (e.g., Sequential Organ Failure Assessment (SOFA) score), sedation levels, organ support therapies (e.g., ventilation, dialysis, Extracorporeal Membrane Oxygenation (ECMO)), and medications administered during ICU stay (e.g., sedatives, vasopressors, corticosteroids).
These exposures represent complications that may be associated with circadian disruption: delirium, deep sedation, ICU-acquired muscle weakness, and post-intensive care syndrome.
These exposures reflect biological clock function: clock gene expression (if available in some cases), and melatonin levels.
TRG-N (ISRCTN77569430)
These are the primary exposures and are used to detect oscillatory patterns and characterize circadian rhythms. They include heart rate, body temperature, blood pressure, blood glucose, and insulin.
These are secondary exposures that may influence circadian rhythms: illness severity (e.g., Sequential Organ Failure Assessment (SOFA) score), sedation levels, organ support therapies (e.g., ventilation, dialysis, Extracorporeal Membrane Oxygenation (ECMO)), and medications administered during ICU stay (e.g., sedatives, vasopressors, corticosteroids).
These exposures represent complications that may be associated with circadian disruption: delirium, deep sedation, ICU-acquired muscle weakness, and post-intensive care syndrome.
These exposures reflect biological clock function: clock gene expression (if available in some cases), and melatonin levels.
These exposures represent metabolic consequences of critical illness: insulin sensitivity, muscle atrophy, and critical illness myopathy or ICU-acquired weakness.
CIPCIM2 (ISRCTN19392591)
These are the primary exposures and are used to detect oscillatory patterns and characterize circadian rhythms. They include heart rate, body temperature, blood pressure, blood glucose, and insulin.
These are secondary exposures that may influence circadian rhythms: illness severity (e.g., Sequential Organ Failure Assessment (SOFA) score), sedation levels, organ support therapies (e.g., ventilation, dialysis, Extracorporeal Membrane Oxygenation (ECMO)), and medications administered during ICU stay (e.g., sedatives, vasopressors, corticosteroids).
These exposures represent complications that may be associated with circadian disruption: delirium, deep sedation, ICU-acquired muscle weakness, and post-intensive care syndrome.
These exposures reflect biological clock function: clock gene expression (if available in some cases), and melatonin levels.
These exposures represent metabolic consequences of critical illness: insulin sensitivity, muscle atrophy, and critical illness myopathy or ICU-acquired weakness.
CGM (NCT02296372)
These are the primary exposures and are used to detect oscillatory patterns and characterize circadian rhythms. They include heart rate, body temperature, blood pressure, blood glucose, and insulin.
These are secondary exposures that may influence circadian rhythms: illness severity (e.g., Sequential Organ Failure Assessment (SOFA) score), sedation levels, organ support therapies (e.g., ventilation, dialysis, Extracorporeal Membrane Oxygenation (ECMO)), and medications administered during ICU stay (e.g., sedatives, vasopressors, corticosteroids).
These exposures represent complications that may be associated with circadian disruption: delirium, deep sedation, ICU-acquired muscle weakness, and post-intensive care syndrome.
HELIA-ICU (NCT05556811)
These are the primary exposures and are used to detect oscillatory patterns and characterize circadian rhythms. They include heart rate, body temperature, blood pressure, blood glucose, and insulin.
These are secondary exposures that may influence circadian rhythms: illness severity (e.g., Sequential Organ Failure Assessment (SOFA) score), sedation levels, organ support therapies (e.g., ventilation, dialysis, Extracorporeal Membrane Oxygenation (ECMO)), and medications administered during ICU stay (e.g., sedatives, vasopressors, corticosteroids).
These exposures represent complications that may be associated with circadian disruption: delirium, deep sedation, ICU-acquired muscle weakness, and post-intensive care syndrome.
These exposures reflect biological clock function: clock gene expression (if available in some cases), and melatonin levels.
PICS-Analyse (EA1/229/24)
These are the primary exposures and are used to detect oscillatory patterns and characterize circadian rhythms. They include heart rate, body temperature, blood pressure, blood glucose, and insulin.
These are secondary exposures that may influence circadian rhythms: illness severity (e.g., Sequential Organ Failure Assessment (SOFA) score), sedation levels, organ support therapies (e.g., ventilation, dialysis, Extracorporeal Membrane Oxygenation (ECMO)), and medications administered during ICU stay (e.g., sedatives, vasopressors, corticosteroids).
These exposures represent complications that may be associated with circadian disruption: delirium, deep sedation, ICU-acquired muscle weakness, and post-intensive care syndrome.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Characterization of circadian periodicities and classification of time-varying patterns based on routine clinical data
기간: From ICU admission to ICU discharge or death, whichever comes first (expected average duration of 4 weeks).
Assessment of periodicities and time-varying patterns in routine clinical parameters, including heart rate, body temperature, blood pressure, blood glucose, and insulin levels. Time-series analysis will be conducted to extract continuous metrics (amplitude, period, and phase). Based on these metrics, patients will be classified into distinct categorical groups according to their periodic oscillation profiles.
From ICU admission to ICU discharge or death, whichever comes first (expected average duration of 4 weeks).

2차 결과 측정

결과 측정
측정값 설명
기간
Association between circadian rhythm category and clinical severity scores
기간: From ICU admission to ICU discharge or death, whichever comes first (expected average duration of 4 weeks).
Relationship between circadian rhythm classification and illness severity (e.g., SOFA score), sedation level, and use of organ support therapies.
From ICU admission to ICU discharge or death, whichever comes first (expected average duration of 4 weeks).
Association between circadian rhythm disruption and critical illness-related conditions
기간: From ICU admission to ICU discharge or death, whichever comes first (expected average duration of 4 weeks), and post-ICU period (up to 3 and 6 months).
Presence of delirium, ICU-acquired muscle weakness/critical illness myopathy, and PICS in relation to circadian rhythm category. Delirium will be measured with the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) binary scale (Positive/Negative).
From ICU admission to ICU discharge or death, whichever comes first (expected average duration of 4 weeks), and post-ICU period (up to 3 and 6 months).
Association between time-varying clinical patterns and external biological markers (from other studies)
기간: Depending on individual study protocols, from ICU admission through 24 months post-discharge. Sampled daily to weekly during the ICU stay, followed by post-discharge examinations conducted at variable monthly intervals (a maximum of 5 visits).
Exploratory associations between oscillatory trends in routine clinical data and biological markers reported in other studies, such as clock gene expression, melatonin levels, insulin sensitivity, muscle atrophy, and critical illness myopathy. Only associations will be evaluated.
Depending on individual study protocols, from ICU admission through 24 months post-discharge. Sampled daily to weekly during the ICU stay, followed by post-discharge examinations conducted at variable monthly intervals (a maximum of 5 visits).
Feasibility and Data Infrastructure for Real-Time Circadian Visualization (Chrono-Apps)
기간: From ICU admission to ICU discharge or death, whichever comes first (expected average duration of 4 weeks).
Evaluation of the technical feasibility and data integration requirements for generating real-time circadian visualizations within the Patient Data Management System (PDMS). Feasibility will be assessed based on data completeness, sampling frequency compliance, latency of time-series data streaming from routine ICU monitors, and system stability required to display continuous circadian profiles via Chrono-Apps.
From ICU admission to ICU discharge or death, whichever comes first (expected average duration of 4 weeks).
Performance of Algorithm-Based Light Therapy Recommendations
기간: From ICU admission to ICU discharge or death, whichever comes first (expected average duration of 4 weeks).
Retrospective evaluation of the accuracy and stability of the time-series analysis designed to estimate circadian phase of routine clinical data (vital signs) and generate individualized lighting schedules.
From ICU admission to ICU discharge or death, whichever comes first (expected average duration of 4 weeks).

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 10월 1일

기본 완료 (추정된)

2029년 5월 31일

연구 완료 (추정된)

2029년 9월 30일

연구 등록 날짜

최초 제출

2026년 7월 18일

QC 기준을 충족하는 최초 제출

2026년 9월 3일

처음 게시됨 (실제)

2026년 9월 10일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 10일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 3일

마지막으로 확인됨

2026년 7월 1일

추가 정보

이 연구와 관련된 용어

추가 관련 MeSH 약관

기타 연구 ID 번호

  • EA1/284/22
  • 541063275 - TRR 418 (기타 보조금/기금 번호: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation))

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다